Eligible patients were aged 16–80 years with histological confirmation of differentiated thyroid cancer requiring radioactive iodine ablation (performance status 0–2, tumour stage T1–T3 with the possibility of lymph-node involvement but no distant
Updated: 11/27/2018 06:46P
NorthStar Medical Radioisotopes, a former Madison company now based in Beloit, has federal approval to become the first U.S. supplier in 30 years whose technology can be used to produce a critical radioactive imaging product -- technetium-99m -- the
Updated: 02/08/2018 01:23P